Search results
Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation
Market Watch· 3 hours agoBristol Myers Squibb on Monday said the Food and Drug Administration has accepted its application seeking approval of an subcutaneous formulation of its blockbuster cancer drug Opdivo. The Princeton ...
Investors Purchase Large Volume of Bristol-Myers Squibb Put Options (NYSE:BMY)
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 69,538 put options on the company. This represents an increase of 76% compared ...
Should You Pick Bristol Myers Squibb Stock At $45?
Forbes· 5 days agoDespite a Q1 beat, BMY stock corrected nearly 10% due to a lower than expected outlook for the full-year. After its recent fall, we think BMY stock has...
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoBristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript April 25, 2024...
McAdam LLC Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 5 days agoMcAdam LLC decreased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Bristol-Myers Squibb (NYSE:BMY) Given Average Rating of “Hold” by Analysts
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) has earned an average rating of “Hold” from the nineteen ratings firms that are currently covering the firm, MarketBeat.com reports. One research ...
If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 3 days agoIt's a reasonable question: If you'd invested $1,000 in pharmaceutical specialist Bristol Myers...
Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a...
Simply Wall St. via Yahoo Finance· 2 days agoIt's easy to match the overall market return by buying an index fund. When you buy individual...
Analyzing Bristol-Myers Squibb Co.
Knox Daily· 7 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
The Hill via AOL· 6 days agoA federal judge on Monday threw out legal challenges to the Medicare negotiation program that had...